These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20884684)

  • 1. Genetic damage in chronic renal failure patients is associated with the glomerular filtration rate index.
    Sandoval SB; Stoyanova E; Coll E; Pastor S; Reyes J; Andrés E; Ballarin J; Xamena N; Marcos R
    Mutagenesis; 2010 Nov; 25(6):603-8. PubMed ID: 20884684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative DNA damage in chronic renal failure patients.
    Stoyanova E; Sandoval SB; Zúñiga LA; El-Yamani N; Coll E; Pastor S; Reyes J; Andrés E; Ballarin J; Xamena N; Marcos R
    Nephrol Dial Transplant; 2010 Mar; 25(3):879-85. PubMed ID: 19889871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic instability in chronic renal failure patients.
    Sandoval SB; Pastor S; Stoyanova E; Rodríguez-Ribera L; García-Quispes WA; Coll E; Reyes J; Andrés E; Ballarin J; Marcos R
    Environ Mol Mutagen; 2012 Jun; 53(5):343-9. PubMed ID: 22467378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of the genomic damage level in haemodialysis patients by folic acid and vitamin B12 supplementation.
    Stopper H; Treutlein AT; Bahner U; Schupp N; Schmid U; Brink A; Perna A; Heidland A
    Nephrol Dial Transplant; 2008 Oct; 23(10):3272-9. PubMed ID: 18469307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical profile and management of hypertensive patients with chronic ischemic heart disease and renal dysfunction attended by cardiologists in daily clinical practice.
    Barrios V; Escobar C; Murga N; de Pablo C; Bertomeu V; Calderón A; Echarri R
    J Hypertens; 2008 Nov; 26(11):2230-5. PubMed ID: 18854765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis.
    Fragedaki E; Nebel M; Schupp N; Sebekova K; Völkel W; Klassen A; Pischetsrieder M; Frischmann M; Niwa T; Vienken J; Heidland A; Stopper H
    Nephrol Dial Transplant; 2005 Sep; 20(9):1936-43. PubMed ID: 15919695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating resistin concentrations in children depend on renal function.
    Nüsken KD; Kratzsch J; Wienholz V; Stöhr W; Rascher W; Dötsch J
    Nephrol Dial Transplant; 2006 Jan; 21(1):107-12. PubMed ID: 16144855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease.
    Malyszko J; Bachorzewska-Gajewska H; Sitniewska E; Malyszko JS; Poniatowski B; Dobrzycki S
    Ren Fail; 2008; 30(6):625-8. PubMed ID: 18661413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function.
    Guebre-Egziabher F; Bernhard J; Funahashi T; Hadj-Aissa A; Fouque D
    Nephrol Dial Transplant; 2005 Jan; 20(1):129-34. PubMed ID: 15585515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes.
    Lin JL; Lin-Tan DT; Hsu KH; Yu CC
    N Engl J Med; 2003 Jan; 348(4):277-86. PubMed ID: 12540640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.
    Axelsson J; Witasp A; Carrero JJ; Qureshi AR; Suliman ME; Heimbürger O; Bárány P; Lindholm B; Alvestrand A; Schalling M; Nordfors L; Stenvinkel P
    Am J Kidney Dis; 2007 Feb; 49(2):237-44. PubMed ID: 17261426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New approaches for the treatment of genomic damage in end-stage renal disease.
    Schupp N; Schmid U; Heidland A; Stopper H
    J Ren Nutr; 2008 Jan; 18(1):127-33. PubMed ID: 18089459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA; Onuigbo NT
    QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment in glomerular filtration rate or glomerular filtration barrier and occurrence of stroke.
    Ovbiagele B
    Arch Neurol; 2008 Jul; 65(7):934-8. PubMed ID: 18625861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of combined urea and creatinine clearance and prediction equations as measures of residual renal function when GFR is low.
    Almond A; Siddiqui S; Robertson S; Norrie J; Isles C
    QJM; 2008 Aug; 101(8):619-24. PubMed ID: 18540009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Renal failure as a factor of vascular aging].
    Ter Arkh; 2007; 79(6):49-52. PubMed ID: 17684967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal function and serum albumin at the start of dialysis in 514 Chinese ESRD in-patients.
    Liu H; Peng Y; Liu F; Xiao H; Chen X; Huang A; Liu Y
    Ren Fail; 2008; 30(7):685-90. PubMed ID: 18704816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney function and cardiovascular disease in the hypertensive population: the ERIC-HTA study.
    Redón J; Cea-Calvo L; Lozano JV; Fernández-Pérez C; Navarro J; Bonet A; González-Esteban J;
    J Hypertens; 2006 Apr; 24(4):663-9. PubMed ID: 16531794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Kidney Disease Epidemiology Collaboration versus Modification of Diet in Renal Disease equations for renal function evaluation in patients undergoing partial nephrectomy.
    Shikanov S; Clark MA; Raman JD; Smith B; Kaag M; Russo P; Wheat JC; Wolf JS; Huang WC; Shalhav AL; Eggener SE
    J Urol; 2010 Nov; 184(5):1867-71. PubMed ID: 20846677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease.
    Lorenzen J; Krämer R; Kliem V; Bode-Boeger SM; Veldink H; Haller H; Fliser D; Kielstein JT
    Eur J Clin Invest; 2010 Apr; 40(4):294-300. PubMed ID: 20486990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.